Efficacy and safety of early radiotherapy combined with first-line chemo-immunotherapy in extensive-stage small-cell lung cancer: a multi-center analysis
Early radiotherapy, either thoracic or extra thoracic radiotherapy, combined with first-line chemo-immunotherapy constituted an effective and well-tolerated strategy for patients with ES-SCLC. These findings warrant investigation in prospective randomized trials.
Authors
- R. Meng
- Yongling Ji
- Yunfeng Wang (ORCID: https://orcid.org/0000-0001-6658-6276)
- Tianle Shen
- Tongfang Zhou
- X. Su
- Y. Lu
- L. Zhao
- X. Fu
- Jingyi Jia
- Ya Zeng
- Bing Xia
- Hui Zhu
- Zhangru Yang
- Xuwei Cai
Institutions
- Shanghai Chest Hospital (CN)
- Zhejiang Cancer Hospital (CN)
- Shandong Tumor Hospital (CN)
- Wuhan Union Hospital (CN)
- Cancer Hospital of Chinese Academy of Medical Sciences (CN)
- Shandong First Medical University (CN)
- Union Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-22
- DOI
- https://doi.org/10.3389/fimmu.2026.1738352
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Chinese Society of Clinical Oncology